Global Intrauterine Contraceptive Devices (IUCD) Market Research Report 2024(Status and Outlook)

Global Intrauterine Contraceptive Devices (IUCD) Market Research Report 2024(Status and Outlook)



Report Overview:

Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.

Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.

The Global Intrauterine Contraceptive Devices (IUCD) Market Size was estimated at USD 3363.50 million in 2023 and is projected to reach USD 3832.63 million by 2029, exhibiting a CAGR of 2.20% during the forecast period.

This report provides a deep insight into the global Intrauterine Contraceptive Devices (IUCD) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intrauterine Contraceptive Devices (IUCD) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intrauterine Contraceptive Devices (IUCD) market in any manner.

Global Intrauterine Contraceptive Devices (IUCD) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bayer Healthcare AG

Teva Pharmaceutical Industries Ltd

Actavis PLC

Medicines360

Trimedic Supply Network Ltd

Medisafe Distribution Inc

Pace Pharmaceuticals Inc

DKT International

Melbea AG

Pregna International Limited

Ocon Medical Ltd

SMB Corporation

Mona Lisa N.V

Market Segmentation (by Type)

Non-hormonal

Hormonal

Inert

Market Segmentation (by Application)

T Shapes

V Shapes

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Intrauterine Contraceptive Devices (IUCD) Market

Overview of the regional outlook of the Intrauterine Contraceptive Devices (IUCD) Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intrauterine Contraceptive Devices (IUCD) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Intrauterine Contraceptive Devices (IUCD)
1.2 Key Market Segments
1.2.1 Intrauterine Contraceptive Devices (IUCD) Segment by Type
1.2.2 Intrauterine Contraceptive Devices (IUCD) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Intrauterine Contraceptive Devices (IUCD) Market Overview
2.1 Global Market Overview
2.1.1 Global Intrauterine Contraceptive Devices (IUCD) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Intrauterine Contraceptive Devices (IUCD) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Intrauterine Contraceptive Devices (IUCD) Market Competitive Landscape
3.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Manufacturers (2019-2024)
3.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Manufacturers (2019-2024)
3.3 Intrauterine Contraceptive Devices (IUCD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Intrauterine Contraceptive Devices (IUCD) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Intrauterine Contraceptive Devices (IUCD) Sales Sites, Area Served, Product Type
3.6 Intrauterine Contraceptive Devices (IUCD) Market Competitive Situation and Trends
3.6.1 Intrauterine Contraceptive Devices (IUCD) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Intrauterine Contraceptive Devices (IUCD) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Intrauterine Contraceptive Devices (IUCD) Industry Chain Analysis
4.1 Intrauterine Contraceptive Devices (IUCD) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Intrauterine Contraceptive Devices (IUCD) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Intrauterine Contraceptive Devices (IUCD) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Type (2019-2024)
6.3 Global Intrauterine Contraceptive Devices (IUCD) Market Size Market Share by Type (2019-2024)
6.4 Global Intrauterine Contraceptive Devices (IUCD) Price by Type (2019-2024)
7 Intrauterine Contraceptive Devices (IUCD) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Intrauterine Contraceptive Devices (IUCD) Market Sales by Application (2019-2024)
7.3 Global Intrauterine Contraceptive Devices (IUCD) Market Size (M USD) by Application (2019-2024)
7.4 Global Intrauterine Contraceptive Devices (IUCD) Sales Growth Rate by Application (2019-2024)
8 Intrauterine Contraceptive Devices (IUCD) Market Segmentation by Region
8.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Region
8.1.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Region
8.1.2 Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Region
8.2 North America
8.2.1 North America Intrauterine Contraceptive Devices (IUCD) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Intrauterine Contraceptive Devices (IUCD) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Intrauterine Contraceptive Devices (IUCD) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Intrauterine Contraceptive Devices (IUCD) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bayer Healthcare AG
9.1.1 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Basic Information
9.1.2 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Product Overview
9.1.3 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.1.4 Bayer Healthcare AG Business Overview
9.1.5 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) SWOT Analysis
9.1.6 Bayer Healthcare AG Recent Developments
9.2 Teva Pharmaceutical Industries Ltd
9.2.1 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Basic Information
9.2.2 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Product Overview
9.2.3 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.2.4 Teva Pharmaceutical Industries Ltd Business Overview
9.2.5 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) SWOT Analysis
9.2.6 Teva Pharmaceutical Industries Ltd Recent Developments
9.3 Actavis PLC
9.3.1 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Basic Information
9.3.2 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Product Overview
9.3.3 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.3.4 Actavis PLC Intrauterine Contraceptive Devices (IUCD) SWOT Analysis
9.3.5 Actavis PLC Business Overview
9.3.6 Actavis PLC Recent Developments
9.4 Medicines360
9.4.1 Medicines360 Intrauterine Contraceptive Devices (IUCD) Basic Information
9.4.2 Medicines360 Intrauterine Contraceptive Devices (IUCD) Product Overview
9.4.3 Medicines360 Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.4.4 Medicines360 Business Overview
9.4.5 Medicines360 Recent Developments
9.5 Trimedic Supply Network Ltd
9.5.1 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Basic Information
9.5.2 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Product Overview
9.5.3 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.5.4 Trimedic Supply Network Ltd Business Overview
9.5.5 Trimedic Supply Network Ltd Recent Developments
9.6 Medisafe Distribution Inc
9.6.1 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Basic Information
9.6.2 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Product Overview
9.6.3 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.6.4 Medisafe Distribution Inc Business Overview
9.6.5 Medisafe Distribution Inc Recent Developments
9.7 Pace Pharmaceuticals Inc
9.7.1 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Basic Information
9.7.2 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Product Overview
9.7.3 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.7.4 Pace Pharmaceuticals Inc Business Overview
9.7.5 Pace Pharmaceuticals Inc Recent Developments
9.8 DKT International
9.8.1 DKT International Intrauterine Contraceptive Devices (IUCD) Basic Information
9.8.2 DKT International Intrauterine Contraceptive Devices (IUCD) Product Overview
9.8.3 DKT International Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.8.4 DKT International Business Overview
9.8.5 DKT International Recent Developments
9.9 Melbea AG
9.9.1 Melbea AG Intrauterine Contraceptive Devices (IUCD) Basic Information
9.9.2 Melbea AG Intrauterine Contraceptive Devices (IUCD) Product Overview
9.9.3 Melbea AG Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.9.4 Melbea AG Business Overview
9.9.5 Melbea AG Recent Developments
9.10 Pregna International Limited
9.10.1 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Basic Information
9.10.2 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Product Overview
9.10.3 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.10.4 Pregna International Limited Business Overview
9.10.5 Pregna International Limited Recent Developments
9.11 Ocon Medical Ltd
9.11.1 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Basic Information
9.11.2 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Product Overview
9.11.3 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.11.4 Ocon Medical Ltd Business Overview
9.11.5 Ocon Medical Ltd Recent Developments
9.12 SMB Corporation
9.12.1 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Basic Information
9.12.2 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Product Overview
9.12.3 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.12.4 SMB Corporation Business Overview
9.12.5 SMB Corporation Recent Developments
9.13 Mona Lisa N.V
9.13.1 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Basic Information
9.13.2 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Product Overview
9.13.3 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Product Market Performance
9.13.4 Mona Lisa N.V Business Overview
9.13.5 Mona Lisa N.V Recent Developments
10 Intrauterine Contraceptive Devices (IUCD) Market Forecast by Region
10.1 Global Intrauterine Contraceptive Devices (IUCD) Market Size Forecast
10.2 Global Intrauterine Contraceptive Devices (IUCD) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Intrauterine Contraceptive Devices (IUCD) Market Size Forecast by Country
10.2.3 Asia Pacific Intrauterine Contraceptive Devices (IUCD) Market Size Forecast by Region
10.2.4 South America Intrauterine Contraceptive Devices (IUCD) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Intrauterine Contraceptive Devices (IUCD) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Intrauterine Contraceptive Devices (IUCD) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Intrauterine Contraceptive Devices (IUCD) by Type (2025-2030)
11.1.2 Global Intrauterine Contraceptive Devices (IUCD) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Intrauterine Contraceptive Devices (IUCD) by Type (2025-2030)
11.2 Global Intrauterine Contraceptive Devices (IUCD) Market Forecast by Application (2025-2030)
11.2.1 Global Intrauterine Contraceptive Devices (IUCD) Sales (K Units) Forecast by Application
11.2.2 Global Intrauterine Contraceptive Devices (IUCD) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings